John Sloan

Associate Professor

Boston University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Sloan is an Associate Professor at Boston University School of Medicine in the United States. His research primarily focuses on hematologic malignancies, particularly the outcomes and treatment strategies associated with AL amyloidosis and stem cell transplantation. Recent articles authored by Professor Sloan investigate various aspects of T-cell lymphotropic virus infections, immune thrombotic thrombocytopenia following vaccination, and the predictive factors affecting patient responses to immunomodulatory treatments.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Hamza Hassan

Boston University

UNITED STATES

View details

Finn Hawkins

Boston University School of Medicine

UNITED STATES

View details

Murali Janakiram

Assistant Professor

University of Minnesota System

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Sloan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation

Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis

Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination

Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis.

Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab.

Primary pulmonary marginal zone lymphoma: an unusual cause of pulmonary infiltrates.

Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs

Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma.

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis

Collaborators (3)

Hamza Hassan

Finn Hawkins

Murali Janakiram

Make your next move.